• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Sarmad Sadeghi, MD, PhD

Latest:

How to Optimize Cancer Therapy When Coronavirus Hits the Fan

The American Society of Clinical Oncology recommends that cancer survivors who have completed their treatment and are under surveillance with no known evidence of disease are to be kept out of care facilities to avoid developing COVID-19.



Julia Driessen, PhD

Latest:

Medicare Shared Savings Program ACO Network Comprehensiveness and Patient Panel Stability

Medicare Shared Savings Program accountable care organization (ACO) network comprehensiveness is associated with stable patient assignment year to year. Panel stability was significantly associated with improved diabetes and hypertension control in the short term.


Daniel P. McKellar, MD, FACS

Latest:

The Oncology Medical Home - Beyond Clinical Pathways

Clinical pathways have been emphasized as a means to deliver efficient, quality care and to ensure better outcomes at lower costs. The Oncology Medical Home takes this to the next, more comprehensive, step of quantifying and improving quality and value in cancer care while lowering overall costs.


Eric T. Roberts, PhD

Latest:

Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare

Among near-poor Black and Hispanic individuals, Medicare Advantage was associated with increased vision care and some, although not uniform, reductions in access disparities vs traditional Medicare.



Natasha Coult, MS

Latest:

Safety Net Representation in Federal Payment and Care Delivery Reform Initiatives

Although safety net organizations are eligible for some two-thirds of federal payment reform programs, fewer than 20% of these programs directly target the safety net.


Dori Bilik, MBA

Latest:

Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities

A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.


Stephanie A. Gernant, PharmD, MS

Latest:

Building Partnerships Between a College of Pharmacy and ACOs: Development of the ACORN SEED

To promote future partnerships among colleges of pharmacy and accountable care organizations, this article describes several initial challenges to partnership formation, including those related to agenda setting and resource utilization.


Patricia Murphy, MPH

Latest:

Impact of an Online Prescription Management Account on Medication Adherence

Online prescription management accounts may help promote medication adherence, as utilizing patients had a higher proportion of days covered than nonusers.



Lauren Abderhalden, MS

Latest:

Characteristics and Medication Use of Veterans in Medicare Advantage Plans

Veterans enrolled in Medicare Advantage plans differed from fee-for-service sector enrollees in several demographic, geographic, and clinical characteristics and in patterns of medication use.






Ian M. Thompson, MD

Latest:

Preliminary Treatment Considerations Among Men With Newly Diagnosed Prostate Cancer

In a survey of local-stage prostate cancer patients, preference for prostatectomy was influenced by perceptions of its efficacy and personal burden versus nonsurgical options.



Luther Scott, MS

Latest:

Race/Ethnicity, Personal Health Record Access, and Quality of Care

Quality benefits were equal across racial/ethnic groups with equal personal health record (PHR) use, but nonwhite status and a preference for Spanish language predicted lower PHR registration.


Ryan Van Loan, BA

Latest:

Medication Burden in Patients With Acute Coronary Syndromes

Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.


Bryan R. Luce, PhD

Latest:

Can Managed Care Organizations Partner With Manufacturers for Comparative Effectiveness Research?

Two case studies examine the benefits of manufacturers and managed care organizations partnering in pragmatic or practical clinical trials to generate real-world evidence.






Yiye Zhang, MS

Latest:

Innovations in Chronic Care Delivery Using Data-Driven Clinical Pathways

This paper demonstrates that data-driven clinical pathways can be developed using electronic health record data to facilitate innovations in practice-based care delivery for chronic disease management.



Lauri Virta, MD, PhD

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.


Megan Bianchetti, MSW

Latest:

Bridging the Care Gap Between Pediatric and Young Adult Cancer

Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.